Stock listing

BCBA:JNJ.CI Johnson & Johnson Acciones

Argentine listing (BCBA) of Johnson & Johnson · home listing NYSE:JNJ

Follow Johnson & Johnson into a list and get an email when it puts out news.

Home listing price · NYSE:JNJ

$255.56 USD +2.28 (+0.9%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:JNJ

Johnson & Johnson logo
Ticker
BCBA:JNJ.CI
Asset type
Stock
Exchange
BCBA
Currency
ARS

What changed lately

Calls

Replays

  • Johnson & Johnson (NYSE:JNJ) Q3 2026 Earnings Call

    Tue, Oct 13, 2026 · 8:30 AM ET

    Watch Transcript

  • Johnson & Johnson (NYSE:JNJ) Q2 2026 Earnings Call

    Wed, Jul 15, 2026 · 8:30 AM ET

    Watch Transcript

  • Johnson & Johnson (NYSE:JNJ) Q1 2026 Earnings Call

    Tue, Apr 14, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

CHMP recommends approval of Johnson & Johnson’s TALVEY®▼ (talquetamab) plus daratumumab in earlier line treatment of relapsed/refractory multiple myeloma

Oct 16, 2026

Johnson & Johnson Q3 2026 earnings: CEO and CFO prepared remarks

Oct 13, 2026

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026

Oct 13, 2026

Johnson & Johnson reports Q3 2026 results, raises 2026 guidance

Oct 13, 2026

TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease

Oct 12, 2026

New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn's disease patient subgroups

Oct 12, 2026

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

Oct 9, 2026

Johnson & Johnson announces new ICOTYDE® (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through 2-years, affirming its use as a powerful first line systemic therapy

Oct 2, 2026

LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

Oct 1, 2026

Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Sep 30, 2026

All Johnson & Johnson news

Decks

Johnson & Johnson on 6ix

News releases
176 in the last 12 months · 184 in all · newest Oct 16, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Oct 13, 2026
Decks
66 decks · latest Oct 13, 2026

Where Johnson & Johnson is listed

ListingExchangeCountryCurrency
NYSE:JNJ · Home listingNYSEUnited StatesUSD
gettex:JNJgettexGermanyEUR
BCBA:JNJBCBAArgentinaARS
Xetra:JNJXetraGermanyEUR
B3:JNJB34B3BrazilBRL
Tradegate:JNJTradegateGermanyEUR
SET:JNJ03SETThailandTHB
BCBA:JNJDBCBAArgentinaUSD
TSX:JNJTSXCanadaCAD
LS Exchange:853260LS ExchangeGermanyEUR
BMV:JNJBMVMexicoMXN
Cboe Canada:JNJCboe CanadaCanadaCAD
BVC:JNJBVCColombiaCOP
Milan:1JNJMilanItalyEUR
Lang & Schwarz:853260Lang & SchwarzGermanyEUR
Frankfurt:JNJFrankfurtGermanyEUR
Munich:JNJMunichGermanyEUR
Turquoise:JNJNTurquoiseUnited KingdomUSD
Stuttgart:JNJStuttgartGermanyEUR
LSE:0R34LSEUnited KingdomUSD
EUROTLX:4JNJEUROTLXItalyEUR
VIE:JNJViennaAustriaEUR
BOATS:JNJBOATSUnited StatesUSD
BCBA:JNJCBCBAArgentinaUSD
BCS:JNJCLBCSChileCLP
SIX Swiss:JNJ.USDSIX SwissSwitzerlandUSD
Hamburg:JNJHamburgGermanyEUR
Hanover:JNJHanoverGermanyEUR
BIVA:JNJBIVAMexicoMXN
BCS:JNJBCSChileUSD
Dusseldorf:JNJDusseldorfGermanyEUR
BX Swiss:JNJBX SwissSwitzerlandCHF
BSESOF:JNJBSESOFBulgariaEUR
SIX Swiss:JNJSIX SwissSwitzerlandCHF
BCBA:JNJ.BBCBAArgentinaARS
Aquis:JNJDAquisUnited KingdomEUR
BVL:JNJUSBVLPeruPEN
gettex:JNJ0gettexGermanyEUR
BX Swiss:JNJUSDBX SwissSwitzerlandUSD
Aquis:JNJDAquisUnited KingdomEUR
Dusseldorf:JNJ0DusseldorfGermanyEUR
Frankfurt:JNJ0FrankfurtGermanyEUR
Lang & Schwarz:A3ET7SLang & SchwarzGermanyEUR
LS Exchange:A3ET7SLS ExchangeGermanyEUR
Munich:JNJ0MunichGermanyEUR
BCBA:JNJ.CI · This pageBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Johnson & Johnson.